PDL BioPharma Inc (PDLI) - Financial and Strategic SWOT Analysis Review

PDL BioPharma Inc (PDLI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights


PDL BioPharma Inc (PDL) formerly Protein Design Labs, Inc., manages a portfolio of patents and royalty assets that include Queen et al. patents and license agreements with various pharmaceutical and biotechnology companies, and royalty and other acquired assets. It offers financing solutions and non-dilutive growth capital to public and private healthcare companies. PDL provides companies, academic institutions and inventors with an immediate financial monetization of royalty streams for acquiring new income generating assets. The company also carries out the humanization of monoclonal antibodies for facilitating the discovery of targeted treatments for cancer and other immunologic diseases. PDL is headquartered in Incline Village, Nevada, the US.

PDL BioPharma Inc Key Recent Developments

Mar 11,2020: PDL BioPharma reports 2019 fourth quarter and full year financial results and announces plan to dissolve the company by year-end 2020
Mar 09,2020: PDL BioPharma announces appointment of Edward A. Imbrogno as vice president and chief financial officer
Feb 28,2020: PDL BioPharma Enters into cooperation agreement with Engine Capital
Dec 23,2019: PDL BioPharma: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers.

Key benefits of buying this profile include:


You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
 


Section 1 - About the Company
PDL BioPharma Inc - Key Facts
PDL BioPharma Inc - Key Employees
PDL BioPharma Inc - Key Employee Biographies
PDL BioPharma Inc - Major Products and Services
PDL BioPharma Inc - History
PDL BioPharma Inc - Company Statement
PDL BioPharma Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
PDL BioPharma Inc - Business Description
Business Segment: Income Generating Assets
Overview
Performance
Business Segment: Medical Devices
Overview
Performance
Business Segment: Pharmaceutical
Overview
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Rest of the World
Performance
Geographical Segment: United States
Performance
PDL BioPharma Inc - Corporate Strategy
PDL BioPharma Inc - SWOT Analysis
SWOT Analysis - Overview
PDL BioPharma Inc - Strengths
PDL BioPharma Inc - Weaknesses
PDL BioPharma Inc - Opportunities
PDL BioPharma Inc - Threats
PDL BioPharma Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
PDL BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
PDL BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
PDL BioPharma Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 11, 2020: PDL BioPharma reports 2019 fourth quarter and full year financial results and announces plan to dissolve the company by year-end 2020
Mar 09, 2020: PDL BioPharma announces appointment of Edward A. Imbrogno as vice president and chief financial officer
Feb 28, 2020: PDL BioPharma Enters into cooperation agreement with Engine Capital
Dec 23, 2019: PDL BioPharma: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers.
Dec 09, 2019: PDL BioPharma announces completion of strategic review process
Nov 06, 2019: PDL BioPharma reports 2019 third quarter financial results
Sep 11, 2019: PDL BioPharma announces favorable decision in Wellstat Diagnostics litigation
Aug 07, 2019: PDL BioPharma reports 2019 second quarter financial results
Jun 25, 2019: PDL BioPharma announces departure of CFO
Jun 24, 2019: Natasha A. Hernday elected to PDL BioPharmas board of directors
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
 


List Of Tables


PDL BioPharma Inc, Key Facts
PDL BioPharma Inc, Key Employees
PDL BioPharma Inc, Key Employee Biographies
PDL BioPharma Inc, History
PDL BioPharma Inc, Subsidiaries
PDL BioPharma Inc, Key Competitors
PDL BioPharma Inc, Ratios based on current share price
PDL BioPharma Inc, Annual Ratios
PDL BioPharma Inc, Annual Ratios (Cont...1)
PDL BioPharma Inc, Annual Ratios (Cont...2)
PDL BioPharma Inc, Interim Ratios
PDL BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
PDL BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
PDL BioPharma Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
 


List Of Figures


PDL BioPharma Inc, Performance Chart (2015 - 2019)
PDL BioPharma Inc, Ratio Charts
PDL BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
PDL BioPharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020
 


PDL BioPharma Inc (PDLI) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

PDL BioPharma Inc (PDL) formerly Protein Design Labs, Inc., manages a portfolio of patents and royalty assets that include Queen et al. patents and license agreements with various pharmaceutical and

USD 250 View Report

PDL BioPharma Inc Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

PDL BioPharma Inc Company Profile is a detailed strategic and analytical report on PDL BioPharma Inc. The 2018 version of the report offers detailed insights into the companys strategies, developments,

USD 200 View Report

Principia Biopharma Inc (PRNB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Principia Biopharma Inc (Principia Biopharma) is a clinical stage biopharmaceutical company that designs and develops oral small molecule drug therapies for immune disorders and cancer. The company, through its proprietary

USD 250 View Report

Sutro Biopharma Inc (STRO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Sutro Biopharma Inc (Sutro Biopharma), formerly Fundamental Applied Biology Inc, discovers, develops and manufactures novel cancer medicines which include antibody-drug conjugates (ADCs), bispecific antibodies, and antibody-based therapeutics targeting immuno-oncology pathways.

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available